VOYA Investment Management
MACK

VOYA Investment Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

VOYA Investment Management’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-7,472
Closed -$73K – 2649
2017
Q2 		$73K Buy
7,472
+992
+15% +$20.3K ﹤0.01% 2626
2017
Q1 		$157K Hold
6,480
– – ﹤0.01% 2355
2016
Q4 		$208K Hold
6,480
– – ﹤0.01% 2273
2016
Q3 		$324 Hold
6,480
– – ﹤0.01% 1992
2016
Q2 		$275K Sell
6,480
-47,280
-88% -$2.58M ﹤0.01% 2078
2016
Q1 		$3.54M Sell
53,760
-15,924
-23% -$831K 0.01% 848
2015
Q4 		$4.33M Sell
69,684
-108,820
-61% -$7.66M 0.01% 808
2015
Q3 		$12M Buy
178,504
+55,263
+45% +$4.51M 0.03% 498
2015
Q2 		$12M Buy
123,241
+9,911
+9% +$943K 0.03% 508
2015
Q1 		$10.6M Buy
113,330
+105,366
+1,323% +$8.97M 0.02% 565
2014
Q4 		$708K Sell
7,964
-703
-8% -$51.2K ﹤0.01% 1692
2014
Q3 		$599K Hold
8,667
– – ﹤0.01% 1785
2014
Q2 		$497K Sell
8,667
-2,451
-22% -$124K ﹤0.01% 1990
2014
Q1 		$441K Hold
11,118
– – ﹤0.01% 2067
2013
Q4 		$467K Buy
11,118
+2,804
+34% +$81.3K ﹤0.01% 2015
2013
Q3 		$249K Hold
8,314
– – ﹤0.01% 2395
2013
Q2 		$440K Buy
+8,314
New +$364K ﹤0.01% 1934

Other funds holding MACK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VOYA Investment Management's MACK Position: Q3 2017 in Review

VOYA Investment Management sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q3 2017, closing a stake of 7,472 shares — an estimated $73K sold.

VOYA Investment Management first reported a position in MACK in Q2 2013 and held it in 17 quarters. The position peaked at $12M in Q2 2015. 73 funds tracked by Wall St. Rank hold MACK as of Q3 2017.

  • VOYA Investment Management reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
  • VOYA Investment Management sold 7,472 Merrimack Pharmaceuticals, Inc. shares in Q3 2017, an estimated $73K.
  • VOYA Investment Management first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2013 and held it in 17 quarters.
  • VOYA Investment Management's Merrimack Pharmaceuticals, Inc. position peaked at $12M in Q2 2015.
  • 73 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q3 2017.

Based on VOYA Investment Management's 13F filing for Q3 2017, filed 14 Nov 2017.